Chronic Lymphocytic Leukemia Clinical Trials 201
August 2022
Clinical trials play a vital role in moving treatment and research advances forward. The Clinical Trials 201 program tackles common misconceptions and provides clear, actionable information about trials, sharing tools and resources for patients with CLL.
Program topics include:
Personalize Your Experience!
Create an account to save items and receive information curated just for you.
Understanding CLL Clinical Trial Terminology
How Are CLL Patients Monitored After a Clinical Trial Concludes?
December 7, 2022
What Happens in Each Phase of a CLL Clinical Trial?
December 7, 2022
What Are the Types of CLL Clinical Trials?
August 3, 2022
CLL Clinical Trials: What Are the Phases?
August 3, 2022
Benefits of CLL Clinical Trails
How Could CLL Patients Benefit From Clinical Trial Participation?
December 7, 2022
What Do CLL Patients Need to Know About Clinical Trials?
December 6, 2022
A CLL Expert Addresses Common Clinical Trial Misconceptions
August 3, 2022
CLL Research Highlights: What Should Patients Know About?
August 3, 2022
CLL Clinical Trial Safety
How Is a Patient’s Safety Monitored in a CLL Clinical Trial?
December 7, 2022
Are CLL Clinical Trials Safe?
August 3, 2022
Accessing CLL Clinical Trials
Developing CLL Research and Treatment News
December 7, 2022
Addressing Racial Disparities in CLL Care
August 3, 2022
How Can CLL Patients Find Clinical Trials?
August 3, 2022
CLL Clinical Trials 201 Resources
CLL Clinical Trials 201 Guide
December 5, 2022
This program is supported by Pharmacyclics, an AbbVie Company, and through generous donations from people like you.